Related Experiment Video
Updated: Apr 23, 2026
07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
40.0K
Decision making in prenatal screening: money matters
E Joanne Verweij1, Diederik Veersema, Eva Pajkrt
1Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands.
Acta Obstetricia Et Gynecologica Scandinavica
|October 2, 2014
Summary
Reimbursement withdrawal significantly reduced first-trimester combined test uptake in younger women. This highlights the financial impact on prenatal screening accessibility and uptake.
Area of Science:
- Prenatal diagnostics
- Public health policy
- Health economics
Background:
- The first-trimester combined test was piloted in the Netherlands before national program introduction.
- Reimbursement for the combined test was abruptly withdrawn for women aged 35 years and younger in January 2007.
- This policy change occurred due to a government decision impacting insurance coverage.
Purpose of the Study:
- To assess the impact of reimbursement withdrawal on the uptake of the first-trimester combined test.
- To analyze changes in combined test utilization among different age groups following the policy change.
Main Methods:
- A comparative study design was employed, analyzing data from before and after the reimbursement change.
- Uptake rates were compared between 2006 (pre-withdrawal) and 2007 (post-withdrawal).
- Statistical analysis, including p-values and confidence intervals, was used to determine significance.
Main Results:
- Overall combined test uptake decreased by 25% from 2006 to 2007.
- A significant decline in uptake was observed in women aged 35 years and younger (p < 0.001).
- Conversely, uptake increased in women aged 36 years and older (p < 0.001).
Conclusions:
- The withdrawal of reimbursement had a substantial negative financial impact on the uptake of the first-trimester combined test.
- The policy disproportionately affected younger pregnant women's access to prenatal screening.
- Healthcare policy decisions regarding reimbursement significantly influence the utilization of prenatal diagnostic services.
More Related Videos
Related Concept Videos
02:46Genetic Screens
4.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.6K
01:30Preventive Healthcare Services
2.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.2K
01:59CRISPR
46.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
46.2K
01:07Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
01:09Decision Making: P-value Method
5.8K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
622
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
622